|Articles|December 11, 2017
Breast Cancer Risk Assessment and Treatment
Advertisement
Personalized medicine is here. It's the responsibility of OB/GYNs, other women's health care clinicians, and primary care providers to understand how it can impact the decisions we and our patients make.
Read two case studies demonstrating the many ways in which genetic testing, breast cancer prognostic tests, and personalized medicine have improved the very foundation of patient care in this area.
Watch the associated video, below!
Learn How SNPs May Assist in Assessing Breast Cancer Risks for Your Patients
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Criminalizing prenatal drug use linked to reduced prenatal care
2
Prenatal COVID-19 exposure linked to adverse offspring neurodevelopment
3
Elisabet Stener-Victorin, PhD, highlights 4 unique PCOS subtypes for personalized care
4
Preterm HDP cases linked to greater CVD death in larger infants
5












